The expression of IGF2BP2 was higher in most of the tumor tissues (n = 28/34) and lower in adrenocortical cancer (ACC) (P < 0.05), PRAD (P < 0.05) and KIPAN (P < 0.05), compared to normal tissues (Figure 1E); IGF2BP2 expression in endometrioid cancer (UCEC) (P > 0.05), bladder cancer (BLCA) (P > 0.05), and kidney chromophobe (KICH) (P > 0.05) tumors was similar to that in normal tissues. Here, IGF2BP2 is linked to urinary bladder cancer.